Using a blood test to reduce antibiotics in preterm newborns
Treatments studied
Part of Genetic & congenital, Infections clinical trials.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born between 24 weeks and 31 weeks and 6 days of pregnancy.
- Your baby must have a moderate risk of early infection, meaning doctors would start antibiotics based on the Dutch guideline.
- Your baby cannot be at low risk (no antibiotics needed) or high risk (signs of serious infection).
- High risk includes conditions like mother having sepsis, need for strong breathing support, or unstable blood pressure requiring medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for premature babies born at 26 to 34 weeks who have risk factors for early infection: giving antibiotics only if they develop signs of infection versus giving them right away. It aims to find out if waiting is safe and reduces unnecessary antibiotic use.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study is testing a new blood test (called presepsin) to see if it can help doctors quickly diagnose sepsis (a serious infection) in newborns. If your baby has signs of infection, this test might help find the cause sooner.
This trial tests whether a new calculator helps doctors decide the best care for newborns at risk of early infection. It looks at babies born at 35 weeks or later who had a blood test for infection.
Hear when a new Early-Onset Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.